Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,721.93
(
0.34%
)
US TECH 100
24,147.20
(
0.55%
)
Dow Jones
47,074.22
(
0.27%
)
Brent Oil
99.84
(
1.56%
)
Bitcoin
74,296.94
(
-0.73%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: None

Friday, 08/01/2008 9:11:30 AM

Friday, August 01, 2008 9:11:30 AM

Post# of 257251
Teva(MNTA) As alluded to by Dew...

Teva-TEVA should benefit from BIIB/ELN's PML disclosure@COWN
Cowen said TEVA's Copaxone has continued to gain share as its efficacy profile has grown in the clinical community. Shares are Outperform rated.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now